|
Volumn , Issue , 2014, Pages 51-59
|
Immunotherapy for glioma: from illusion to realistic prospects?
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CANCER VACCINE;
TUMOR ANTIGEN;
ADOPTIVE IMMUNOTHERAPY;
ADVERSE EFFECTS;
ANIMAL;
BRAIN NEOPLASMS;
GENE THERAPY;
GLIOMA;
HUMAN;
IMMUNIZATION;
IMMUNOLOGY;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
T LYMPHOCYTE;
TRANSPLANTATION;
TREATMENT OUTCOME;
TUMOR ASSOCIATED LEUKOCYTE;
TUMOR ESCAPE;
ANIMALS;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
BRAIN NEOPLASMS;
CANCER VACCINES;
GENETIC THERAPY;
GLIOMA;
HUMANS;
IMMUNIZATION;
IMMUNOTHERAPY, ADOPTIVE;
LYMPHOCYTES, TUMOR-INFILTRATING;
MOLECULAR TARGETED THERAPY;
T-LYMPHOCYTES;
TREATMENT OUTCOME;
TUMOR ESCAPE;
|
EID: 84945992545
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.14694/EdBook_AM.2014.34.51 Document Type: Review |
Times cited : (3)
|
References (0)
|